3-bromo-N,N-dimethyladamantan-1-amine
- $237 - $1328.25
- Product name: 3-bromo-N,N-dimethyladamantan-1-amine
- CAS: 944-10-5
- MF: C12H21Br2N
- MW: 339.10984
- EINECS:
- MDL Number:MFCD00167823
- Synonyms:(3-bromo-1-adamantyl)dimethylamine hydrobromide;3-bromo-N,N-dimethyladamantan-1-amine
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 0.5G
- 500mg
- 1G
- 5G
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0108774
- Product description(3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00%
- Packaging5G
- Price$1328.25
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0108774
- Product description(3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00%
- Packaging1G
- Price$750.75
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0108774
- Product description(3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00%
- Packaging0.5G
- Price$682
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number060541
- Product description(3-Bromo-1-adamantyl)dimethylamine hydrobromide
- Packaging500mg
- Price$237
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0108774 | (3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00% | 5G | $1328.25 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0108774 | (3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00% | 1G | $750.75 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0108774 | (3-BROMO-1-ADAMANTYL)DIMETHYLAMINE HYDROBROMIDE 95.00% | 0.5G | $682 | 2021-12-16 | Buy |
Matrix Scientific | 060541 | (3-Bromo-1-adamantyl)dimethylamine hydrobromide | 500mg | $237 | 2021-12-16 | Buy |
Properties
Melting point :252-253 °C
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|